StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Core Operating Income Margin by Quarter

Core Operating Income Margin (%) (%)

QuarterlyAnnual

Novartis Core Operating Income Margin: 41.6% in Q3 2026, up 2.3 pts from a year earlier.

Latest, Q3 2026
41.6%
Period ended Sep 30, 2026
Change on a year earlier
+2.3 pts
39.3% in Q3 2025
History
16 quarters
Since Q4 2022
Sources
12
Documents cited below

Where the Q3 2026 figure comes from

“|| % of net sales | 41.6 | 39.3 | 40.1 | 41.2”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCore Operating Income Margin (%) (%)Year on yearSource
Q3 2026Sep 30, 202641.6%+2.3 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202641.2%-1.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202637.3%-4.8 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202537.0%+0.1 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 202539.3%-0.8 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 202542.2%+2.6 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 202542.1%+3.7 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 202436.9%+3.4 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 202440.1%+2.7 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 202439.6%+2.5 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 202438.4%+2.2 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 202333.5%-1.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 202337.4%–Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 202337.1%–Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 202336.2%–Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 202234.5%–Novartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis Core Operating Income Margin (%), quarterly Q4 2022–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/core-operating-margin-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.